Fortitude Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ATO
Fortitude Advisory Group's ABBV Position: Q2 2026 in Review
Fortitude Advisory Group increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $112K and bringing the position to 5,707 shares worth $1.44M. The position accounts for 0.55% of the portfolio, ranked #37.
Fortitude Advisory Group first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 1,758 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Fortitude Advisory Group held 5,707 shares of AbbVie worth $1.44M as of Q2 2026.
- Fortitude Advisory Group bought 521 AbbVie shares in Q2 2026, an estimated $112K.
- AbbVie made up 0.55% of Fortitude Advisory Group's portfolio in Q2 2026, its #37 holding.
- Fortitude Advisory Group first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 1,758 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Fortitude Advisory Group's 13F filing for Q2 2026, filed 22 Jul 2026.